相关实验视频
Updated: Jun 15, 2025
02:22
Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection
Published on: April 12, 2024
291
脑下垂体肥胖:罕见细胞/细胞上瘤的流行病学 - - 一个德国的索赔数据库分析
Julian Witte1, Bastian Surmann1, Manuel Batram1
1Vandage GmbH, Bielefeld, Germany.
Journal of neuroendocrinology
|August 27, 2024
概括
这项研究估计了德国瘤/治疗相关的下丘脑肥胖 (HO) 发生率,每年每百万发现0.7-1.7例. 它确定了儿童/年轻成人和中年成人两种发病率峰值.
科学领域:
- 内分泌学 在内分泌学.
- 神经科学是一个神经科学.
- 流行病学 流行病学
背景情况:
- 脑下垂体肥胖症 (HO) 是从脑下垂体损伤引起的严重肥胖症.
- 对于HO的流行病学,特别是与瘤/治疗相关的HO (TTR-HO),尚不清楚.
- 准确的发病率和流行率数据对于了解TTR-HO负担至关重要.
研究的目的:
- 开发和应用数据库算法,用于标准化识别TTR-HO患者.
- 估计德国医疗保健系统中TTR-HO的发生率和流行率.
- 为了确定与TTR-HO.HO相关的人口结构模式和常见的瘤类型.
主要方法:
- 开发了一个数据库算法,使用索赔数据 (2010-2020) 识别TTR-HO患者.
- 包括手术/放射治疗和HO相关瘤的患者,验证HO与发生的无味糖尿病和desmopressin.
- 进行敏感性分析以评估算法定义的不确定性.
主要成果:
- 估计德国每年TTR-HO发病率在每10万人中为0.7至1.7例.
- 在2019年确定了1262名TTR-HO患者,发病率高峰在10-24岁和40-44岁的人群中.
- 最常见的相关瘤是良性细胞/细胞上瘤,垂体瘤和内分泌腺瘤.
结论:
- 这是对TTR-HO流行病学的第一个真实世界数据库分析.
- 提供了对TTR-HO发病率和流行率的精细估计,有助于早期患者识别.
- 为了获得最佳的治疗策略,需要进一步描述和了解临床影响.
相关概念视频
01:24Obesity
416
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
416
01:15Hypoglycemia and Glucagon
218
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
218
01:21Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334